Model developed by startup supported by FAPESP enables scientists to assess efficacy and safety of sunscreens and anti-aging products under conditions closely resembling real life.
Devices developed by Brazilian startup BioLambda decontaminate face shields, surfaces, workspaces and air.
Brazilian startup Agrobee signs agreement with Agroven, an investment club run by family farmers who want to promote technological development in the sector.
Laboratory tests showed film containing silver-silica nanoparticles to be capable of eliminating 99.84% of SARS-CoV-2 particles after exposure for two minutes.
The conventional process requires costly large-scale equipment. The novel method can be executed in a single step by a device no larger than a microwave oven.
Integrated with the air quality management tool created by startup Omni-electronica, a collector captures viruses suspended in the environment and submits the air samples to RT-PCR testing. Monitoring of crowded locations combined with indicators created by the firm can contribute to a safer economic reopening.
Brazilian researchers studied the morphology of owl wings in search of characteristics that enable these birds to fly silently.
Portable nuclear magnetic resonance device designed with FAPESP’s support will inform consumers regarding value added to beef products.
An electrical impedance tomography system was developed by a São Paulo-based startup to monitor the lungs of patients on mechanical ventilation uninterruptedly and noninvasively.
The startup’s founders were researchers at the University of São Paulo and adjusted their marketing strategy to focus on regenerative, veterinary and sports medicine thanks to training provided by PIPE, FAPESP’s program for Innovative Research in Small Business.
Program developed by startup with FAPESP’s support was initially designed to train cognitive skills and help improve physical fitness but will now have extended functionality.
Through a project supported by FAPESP, the São Paulo-based firm is developing an RT-qPCR diagnostic kit in which all reactions take place in a single tube.
In laboratory tests, the material inactivated 99.9% of SARS-CoV-2 in two minutes. The technology developed by the startup, which is supported by PIPE-FAPESP, will be used to produce face masks and hospital apparel.
The open-access tool was developed in Brazil by researchers at the Center for Mathematical Sciences Applied to Industry to minimize the risk of shortages and overspending.
The project is supported by FAPESP’s Innovative Research in Small Business Program. The firm plans to produce ELISA kits that will detect antibodies against the novel coronavirus in blood serum.
